type 1 diabetes – Medxy AI

Advancing SGLT Inhibitor Use for Heart and Kidney Protection in Type 1 Diabetes: Opportunities and Challenges

By MedXY 09/14/2026

This article reviews expert perspectives on the efficacy and safety of SGLT inhibitors for cardiovascular and renal disease in type 1 diabetes, outlines translational insights from type 2 diabetes data, and proposes a roadmap for regulatory approval and clinical implementation focusing on surrogate endpoints and diabetic ketoacidosis risk mitigation.

Diabetes & Endocrinology news

β-Cell Dysfunction Enhances Prediction of Type 1 Diabetes Progression in Individuals with Single Autoantibody Positivity

By MedXY 09/14/2026

Assessment of β-cell dysfunction using stimulated glucose and C-peptide measures improves risk stratification for type 1 diabetes progression among single autoantibody-positive relatives, enabling personalized monitoring and targeted interventions.

Diabetes & Endocrinology news Public Health

New International Consensus: Screening the General Population for Islet Autoantibodies to Detect Early-Stage Type 1 Diabetes

By MedXY 09/13/2026

An international expert consensus recommends practical principles and minimum requirements for general‑population screening for islet autoantibodies to detect early-stage type 1 diabetes, reduce DKA, enable early care and access to disease‑modifying therapies.

Diabetes & Endocrinology news Pediatrics

Teplizumab Preserves Beta Cell Function in Youth with Newly Diagnosed Type 1 Diabetes: Insights from the PROTECT Trial Per-Protocol Analysis

By MedXY 09/13/2026

The PROTECT trial's per-protocol analysis confirms teplizumab's efficacy in preserving beta cell function, reducing insulin needs, and improving glycemic control in children and adolescents newly diagnosed with stage 3 type 1 diabetes, regardless of HLA subtype or autoantibody profile.

Clinical Updates Diabetes & Endocrinology news

Continuous Glucose Monitoring Using the FreeStyle Libre Pro iQ in Presymptomatic Type 1 Diabetes: Advancements in Early Detection and Risk Stratification

By MedXY 09/11/2026

This review examines the role of FreeStyle Libre Pro iQ CGM in differentiating presymptomatic stages of type 1 diabetes and predicting progression to clinical disease, comparing its performance with Dexcom G6 and discussing implications for clinical practice.

Diabetes & Endocrinology news Pediatrics

Rising Incidence of Islet Autoimmunity Among Colorado Children With Moderate-Risk HLA Genotypes: Insights From Longitudinal Cohorts

By MedXY 09/11/2026

A study reveals a significant secular increase in islet autoimmunity incidence among Colorado children from 1993 to 2010, particularly in those with moderate-risk HLA genotypes, highlighting evolving risk profiles beyond known environmental exposures.

Diabetes & Endocrinology news

Disentangling Fear and Hypoglycemia Metrics in Type 1 Diabetes: Insights from a 12-Month Diabetes Technology Study

By MedXY 09/09/2026

This 12-month analysis in adults with type 1 diabetes using advanced diabetes technology reveals that fear and perceived hypoglycemia frequency do not straightforwardly relate to continuous glucose monitoring metrics, highlighting complex drivers beyond glycemic data.

Diabetes & Endocrinology news

Improved Glycaemic Control and Vascular Outcomes After MiniMed 780G Usage in Older Adults with Type 1 Diabetes: A Randomised Controlled Trial

By MedXY 09/08/2026

This study demonstrates that using the MiniMed 780G hybrid closed-loop system significantly improves glycaemic management and shows a trend toward better microvascular function in adults aged 65 and above with type 1 diabetes, without increasing hypoglycaemia risk.

Diabetes & Endocrinology news

Preserved Endogenous Insulin Production Significantly Reduces Diabetic Ketoacidosis Risk in Type 1 Diabetes

By MedXY 09/08/2026

Detectable C-peptide levels indicating residual insulin production strongly correlate with lower diabetic ketoacidosis risk in type 1 diabetes, highlighting the importance of preserving beta-cell function for improved clinical outcomes.

Diabetes & Endocrinology news Pediatrics

Autoantibody Screening in Sibling-Dominant Pediatric Relatives of Type 1 Diabetes Patients: Prevalence, Determinants, and Psychological Impact

By MedXY 09/06/2026

This multicentre Turkish study identifies ZnT8 autoantibodies as predominant in young siblings at risk for type 1 diabetes and highlights gestational age as a protective factor, while revealing significant anxiety changes in children and parents post-screening, underscoring the need for integrated immunological and psychological care.

Diabetes & Endocrinology news OB/GYN & Women's Health

Menstrual Cycle Influence on Insulin Sensitivity in Type 1 Diabetes: Insights from Automated Insulin Delivery Users

By MedXY 09/06/2026

This study elucidates how insulin sensitivity and glucose control in menstruating individuals with type 1 diabetes fluctuate across menstrual cycle phases, emphasizing gaps in current automated insulin delivery systems and guidelines.

Allergy & Immunology Diabetes & Endocrinology news

Unraveling Genetic Pathways in Type 1 Diabetes: Distinct HLA-DR3 and DR4 Effects on Disease Progression

By MedXY 09/05/2026

This study reveals that genetic risk factors and immune pathways differ significantly between type 1 diabetes patients stratified by HLA-DR3 and HLA-DR4 status, providing insights into disease heterogeneity and personalized risk mechanisms.

Clinical Updates news

Rotavirus Vaccination and Type 1 Diabetes Incidence: Insights from a Norwegian Population-Based Natural Experiment

By MedXY 08/30/2026

Norwegian cohort data reveal no protective effect of rotavirus vaccination against type 1 diabetes onset in early childhood, clarifying prior conflicting findings.

Diabetes & Endocrinology news

Optimizing Capillary Ketone Testing Frequency to Predict Short-Term Diabetic Ketoacidosis Risk in Type 1 Diabetes

By MedXY 08/30/2026

Weekly well-day capillary ketone testing maintains predictive accuracy for 1-month diabetic ketoacidosis risk, offering a practical and less burdensome monitoring strategy for patients with type 1 diabetes.

Diabetes & Endocrinology news Public Health

Financial Toxicity and Cost-Related Nonadherence: Challenges in Adult Type 1 Diabetes Management

By MedXY 08/28/2026

Adults with type 1 diabetes face substantial financial toxicity and cost-related nonadherence, especially younger adults, underscoring the need for targeted interventions beyond traditional social determinants of health.

Diabetes & Endocrinology news Pediatrics

Fecal Short-Chain Fatty Acids in Mother-Infant Dyads: No Direct Link to Islet Autoimmunity Development

By MedXY 08/25/2026

A longitudinal study shows no association between fecal short-chain fatty acid levels during pregnancy and early childhood with the progression to islet autoimmunity in children at risk for type 1 diabetes.

Diabetes & Endocrinology news Public Health

Racial, Ethnic, and Socioeconomic Disparities in Islet Autoantibody Patterns Among Individuals at Risk for Type 1 Diabetes

By MedXY 08/24/2026

Islet autoantibody positivity varies significantly among racial and ethnic groups and is influenced by socioeconomic deprivation, implicating tailored screening and prevention strategies for equitable diabetes care.

Diabetes & Endocrinology news

Durability of β-Cell Function After Cessation of Baricitinib Immunotherapy in New-Onset Type 1 Diabetes

By MedXY 08/22/2026

Baricitinib treatment in recent-onset type 1 diabetes preserves β-cell function during therapy. However, this effect diminishes within a year after stopping treatment, highlighting the need for sustained immunotherapy for lasting benefit.

Diabetes & Endocrinology news

Enhancing MODY Diagnosis: The Clinical Value of Type 1 Diabetes Genetic Risk Scoring in Routine Genetic Testing

By MedXY 08/19/2026

Incorporating a type 1 diabetes genetic risk score into MODY genetic testing helps identify misdiagnosed T1D cases, particularly in children, optimizing diagnostic accuracy and reducing unnecessary testing.

Diabetes & Endocrinology news

Belatacept and Sirolimus Show Promise as Safer Immunosuppression in Islet Transplantation for Type 1 Diabetes

By MedXY 08/18/2026

A multi-centre phase 2 study demonstrates that belatacept combined with sirolimus achieves superior islet transplant outcomes with better renal preservation compared to conventional tacrolimus-based therapy in type 1 diabetes patients.